ABB  Vol.4 No.10 A , October 2013
Effect of estrogen on manganese-induced toxicity on embryonic astrocytes
Abstract: Manganese (Mn) is a natural trace metal that is essential for many physiological functions in the human body. Astrocytes in the central nervous system are susceptible reservoirs for Mn accumulation. Estrogen, a steroidal hormone, has been shown to mitigate Mn-induced toxicity in cultures of postnatal astrocytes. However, differences in expression/inducibility of glutamate transporters and glutamine synthetase, transmitters, and the natural gonadal steroids and their receptors are known to occur in astrocyte cultures derived from various stages of fetal and postnatal development. Cultures of embryonic (E18) hippocampal astrocytes were examined in this study for the ability of 17 β-estradiol (E2) to protect them from Mn toxicity by up regulating gene expression of a glutamate transporter. Primary rat hippocampal astrocytes were pretreated with β-Estradiol (E2) in vitro and subsequently, Mn sulfate (MnSO4). The amount of toxic damage to the astrocytes was measured by quantifying glial fibrillary acidic protein (GFAP) with a sandwiched Enzyme-Linked Immunosorbent Assay (ELISA). ELISA analysis indicated Mn exposure at 100 μM, 300 μM, or 600 μM significantly increased GFAP levels. However, E2 concentrations at 10 nM or 30 nM significantly reduced Mn-induced GFAP concentrations at 100 μM. Cells pretreated with 10 nM or 30 nM of E2 significantly lowered GFAP levels. The Water-Soluble Tetrazolium-8 (WST-8) method was utilized to determine cell viability. The WST-8 assay showed that Mn concentrations of 100 μM, 300 μM, or 600 μM significantly reduced the dehydrogenase activity, thereby decreasing the number of viable astrocytes. Enzyme activity with 600 μM of Mn was significantly decreased when compared with 100 μM of Mn, revealing a dose-dependent effect. However, the dehydrogenase activity in cells treated with 600 μM Mn was significantly increased when pretreated with 10 nM of E2. Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) was used to measure changes in glutamate transporter-1 gene expression in astrocytes after pretreatment of E2 and subsequently, Mn. PCR analysis showed that when cells were exposed to 300 μM Mn, the GLT-1 gene expression was reduced compared to the control. Data also showed that the GLT-1 mRNA was upregulated in cells pretreated with 10 nM E2. When the cells were pretreated with 10 nM E2 and subsequently, 300 μM Mn, there was an increase in the GLT-1 gene expression. The experimental results indicate that E2 can attenuate some Mn-induced toxicity in E18 astrocytes.
Cite this paper: Huynh, T. , Baker, K. and Komiskey, H. (2013) Effect of estrogen on manganese-induced toxicity on embryonic astrocytes. Advances in Bioscience and Biotechnology, 4, 9-15. doi: 10.4236/abb.2013.410A1002.

[1]   Henriksson, J. and Tjalve, H. (2000) Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. Toxicological Sciences, 55, 392-398.

[2]   Sidoryk-Wegrzynowicz, M. and Aschner, M. (2013) Role of astrocytes in manganese mediated neurotoxicity. BMC Pharmacology and Toxicology, 14, 1-10.

[3]   Aschner, M., Gannon, M. and Kimelberg, H.K. (1992) Manganese uptake and efflux in cultured rat astrocytes. Journal Neurochemistry, 58, 730-735.

[4]   Aschner, M., Guilarte, T.R., Schneider, J.S. and Zheng, W. (2007) Manganese: Recent advances in understanding its transport and neurotoxicity. Toxicology Applied Pharmacology, 221, 131-147.

[5]   Gorovits, R., Avidan, N., Avisar, N., Shaked, I. and Vardimon, L. (1997) Glutamine synthetase protects against neuronal degeneration in injured retinal tissue. Proceedings National Academy Science USA, 94, 7024-7029.

[6]   Erikson, K. and Aschner, M. (2002) Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology, 23, 595-602.

[7]   Desole, M.S., Sciola, L., Delogu, M.R., Sircana, S., Migheli, R. and Miele, E. (1997) Role of oxidative stress in the manganese and 1-methyl-4-(2’-ethylphenyl)-1,2,3,5-tetrahydropyridine-induced apoptosis in PC12 cells. Neurochemistry International, 31, 169-176.

[8]   Sidoryk-Wegrzynowicz, M., Lee E., Albrecht, J. and Aschner, M. (2009) Manganese disrupts astrocyte glutamine transporter expression and function. Journal Neurochemistry, 110, 822-830.

[9]   Deng, Y., Xu, Z., Xu, B., Xu, D., Tian, Y. and Feng, W. (2012) The protective effects of riluzole on manganeseinduced disruption of glutamate transporters and glutamine synthetase in the cultured astrocytes. Biological Trace Element Research, 148, 242-249.

[10]   Lee, E.S., Sidoryk, M., Jiang, H., Yin, Z. and Aschner, M. (2009) Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes. Journal Neurochemistry, 110, 530-544.

[11]   Lee, E., Yin, Z., Milatovic, D., Jiang, H. and Aschner, M. (2009). Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicological Sciences, 110, 156-167.

[12]   Zwingmann, C., Leibfritz, D. and Hazell, A.S. (2003) Energy metabolism in astrocytes and neurons treated with manganese: Relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis. Journal of Cerebral Blood Flow and Metabolism, 23, 756-771.

[13]   Erikson, K.M., Dorman, D.C., Lash, L.H. and Aschner, M. (2007) Manganese inhalation by rhesus monkeys are associated with brain regional changes in biomarkers of neurotoxicity. Toxicological Sciences, 97, 459-466.

[14]   Hertz, L., Bock, E. and Schousboe, A. (1978) GFA content, glutamate uptake and activity of glutamate metabolizing enzymes in differentiating mouse astrocytes in primary cultures. Developmental Neuroscience, 1, 226-238.

[15]   Stanimirovic, D.B., Ball, R., Small, D.L. and Muruganandam, A. (1999) Developmental regulation of glutamate transporters and glutamine synthetase activity in astrocyte cultures differentiated in vitro. International Journal of Developmental Neuroscience, 17, 173-184.

[16]   Abe, K. and Saito, H. (1999) Effect of ATP on astrocyte stellation is switched from suppressive to stimulatory during development. Brain Research, 850, 150-157.

[17]   Abe, K. and Saito, H. (1997) Developmental changes in cyclic AMP-stimulated stellation of cultured rat cortical astrocytes. Japanese Journal Pharmacology, 75, 433-438.

[18]   Quadros, P.S., Pfau, J.L., Goldstein, A.Y.N., De Vries, G.J. and Wagner, C.K. (2002) Sex differences in progesterone receptor expression: A potential mechanism for estradiol-mediated sexual differentiation. Endocrinology, 143, 3727-3739.

[19]   Quadros, P.S., Pfau, J.L. and Wagner, C.K. (2007) Distribution of progesterone receptor immunoreactivity in the fetal and neonatal rat forebrain. The Journal of Comparative Neurology, 504, 42-56.

[20]   O’Callaghan, J.P. (1993) Quantitative features of reactive gliosis following toxicant-induced damage of the CNS. In: Johannessen, J.N., Ed., Markers of Neuronal Injury and Degeneration, Academic Science, 679, 195-210.

[21]   Lee, E., Sidoryk-Wegrzynowicz, M., Wang, N., Webb, A., Son, D., Lee, K. and Aschner, M. (2012) GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes. Journal of Biological Chemistry, 287, 26817-26828.

[22]   Steel, R.G.D. and Torrie, J.H. (1960) Principles and procedures of statistics. McGraw, New York.

[23]   Rozovsky, I., Wei, M., Stone, D.J., Zanjani, H., Anderson, C.P., Morgan, T.E. and Finch, C.E. (2002) Estradiol (E2) enhances neurite outgrowth by repressing glial fibrillary acidic protein expression and reorganizing laminin. Endocrinology, 143, 636-646.

[24]   Nelson, D.L. and Cox, M.M. (2008) Principles of Biochemistry, 5th Edition, W H. Freeman and Company, New York.

[25]   Powers, C.M., Bale, A.S., Kraft, A.D., Makris, S.L., Trecki, J., Cowden, J., Hotchkiss, A. and Gillespie, P.A. (2013) Developmental neurotoxicity of engineered nanomaterials: Identifying research needs to support human health risk assessment. Toxicological Sciences, 134, 1-10.

[26]   Alaimo, A., Gorojod, R.M. and Kotler, M.L. (2011) The extrinsic and intrinsic apoptotic pathways are involved in manganese toxicity in rat astrocytoma C6 cells. Neurochemistry International, 59, 297-308.

[27]   Lee, E., Yin, Z., Milatovic, D., Jiang, H. and Aschner, M. (2009) Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicological Sciences, 110, 156-167.

[28]   Pawlak, J., Brito, Kuppers, E. and Beyer, C. (2005) Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Molecular Brain Research, 138, 1-7.

[29]   Novella, S., Dantas, A.P., Segarra, G. Medina, P. and Hermenegildo, C. (2012) Vascular aging in women: Is estrogen the fountain of youth? Frontiers in Physiology, 3, 1-8.

[30]   Lee, E., Sidoryk-Wegrzynowicz, M., Yin, Z., Webb, A., Son, D. and Aschner, M. (2012) Transforming growth factor-α mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes. Glia, 60, 1024-1036.

[31]   Erikson, K. and Aschner, M. (2002) Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology, 23, 595-602.